GB201511453D0 - Treatment of alzheimer's disease - Google Patents

Treatment of alzheimer's disease

Info

Publication number
GB201511453D0
GB201511453D0 GBGB1511453.1A GB201511453A GB201511453D0 GB 201511453 D0 GB201511453 D0 GB 201511453D0 GB 201511453 A GB201511453 A GB 201511453A GB 201511453 D0 GB201511453 D0 GB 201511453D0
Authority
GB
United Kingdom
Prior art keywords
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1511453.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB1511453.1A priority Critical patent/GB201511453D0/en
Publication of GB201511453D0 publication Critical patent/GB201511453D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
GBGB1511453.1A 2015-06-30 2015-06-30 Treatment of alzheimer's disease Ceased GB201511453D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1511453.1A GB201511453D0 (en) 2015-06-30 2015-06-30 Treatment of alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1511453.1A GB201511453D0 (en) 2015-06-30 2015-06-30 Treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
GB201511453D0 true GB201511453D0 (en) 2015-08-12

Family

ID=53872437

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1511453.1A Ceased GB201511453D0 (en) 2015-06-30 2015-06-30 Treatment of alzheimer's disease

Country Status (1)

Country Link
GB (1) GB201511453D0 (en)

Similar Documents

Publication Publication Date Title
IL285722A (en) Methods for treating alzheimer's disease
ZA201605341B (en) Methods of treating alzheimer's disease
IL247085A0 (en) Methods of treating alzheimer's disease
IL263433A (en) Methods for treating alzheimer's disease
EP3268086A4 (en) Lsd for the treatment of alzheimer's disease
IL263188B (en) Treatment for parkinson's disease
HK1243709A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease
PL3137097T3 (en) Treatment and prevention of alzheimer's disease (ad)
PL3137093T3 (en) Treatment and prevention of alzheimer's disease (ad)
PL3137094T3 (en) Treatment and prevention of alzheimer's disease (ad)
GB201622116D0 (en) Treatment of liver disease
GB201511453D0 (en) Treatment of alzheimer's disease
ZA202001588B (en) Method of treating alzheimer's disease
IL263837A (en) Treatment of ocular disease
HK1245081A1 (en) Methods for treating alzheimer's disease
ZA201807944B (en) Treatment for parkinson's disease
GB201621398D0 (en) Treatment of emt-associated disease
GB201504144D0 (en) Treatment of Parkinson's disease
GB201518052D0 (en) Parkinson's disease treatment
GB201610938D0 (en) Treatment of ocular disease
GB201614863D0 (en) Alzheimer's disease
GB201504413D0 (en) Treatment of disease
GB201414038D0 (en) Alzheimer's disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)